MNDR Partners with Jospong to Launch AI-Driven Digital Healthcare Ecosystem in Ghana

Joint Venture Structure and Capitalization Details

The definitive joint venture agreement formalizes the partnership between MNDR and Jospong, converting their August 2025 Memorandum of Understanding into a fully funded and operational entity. MHNS Ghana Limited will exclusively deploy and manage MNDR's proprietary digital healthcare ecosystem within Ghana's healthcare sector.

Capitalized at US$2.5 million, the joint venture balances contributions with MNDR providing proprietary technology valued at US$1.225 million and Jospong supplying US$1.275 million in cash. This structure aligns with MNDR's asset-light, technology-driven growth approach and leverages Jospong's strong local market presence, infrastructure, and capital. The agreement establishes a ten-year term initially, with renewal options for additional five-year periods subject to mutual consent.

Governance and Strategic Partnership Alignment

The agreement incorporates balanced governance provisions to ensure joint oversight of strategic, financial, and operational decisions. Both MNDR and Jospong will have board representation within MHNS Ghana Limited, with reserved matters protecting against unilateral decisions on critical partnership issues.

Roles are clearly defined: Jospong will lead regulatory, statutory, and stakeholder engagement activities in Ghana, leveraging its extensive multi-sector experience across Ghana and other African countries. MNDR will supply the technology platform, technical documentation, and implementation support necessary for successful deployment and ongoing operation within Ghana's regulatory framework.

Capabilities of the Digital Healthcare Ecosystem and Service Offerings

MNDR's digital primary care ecosystem serves as an integrated digital infrastructure connecting patients, healthcare providers, employers, and service vendors. The platform includes multiple complementary modules addressing various healthcare delivery and engagement aspects, contingent on local approvals and readiness in Ghana.

Features include teleconsultation and care access to enhance primary care availability through digital consultations and connected care pathways. AI-powered tools assist patient engagement, care navigation, clinical workflows, and personalized health interactions. The ecosystem integrates diagnostics and data management, linking diagnostic services, patient information systems, and healthcare analytics. Additional commercial offerings encompass employer health and benefits programs, a curated healthcare marketplace, and communities of care focused on specific health conditions to support education and care continuity.

Phased Deployment Plan for Ghana and Regional Growth

The joint venture outlines a phased growth strategy to establish Ghana as a scalable regional model while mitigating regulatory, operational, and market adoption risks. This approach depends on regulatory approvals, effective governance, and proven market readiness at each stage.

Phase 1 involves launch and localization, including securing regulatory approvals, adapting technology and operating models, onboarding initial healthcare and enterprise partners, and initiating services in Ghana. Phase 2 aims to expand the ecosystem by increasing service offerings across primary care, diagnostics, employer health, patient engagement, and marketplace channels. Phase 3 contemplates regional expansion by evaluating entry into other Sub-Saharan African markets using the Ghana-proven technology, governance, and operational blueprint. This phased approach validates the business model, refines operations, and builds institutional knowledge prior to geographic expansion.

Compliance, Cybersecurity, and Data Protection Measures

MHNS Ghana Limited will operate under a compliance-by-design framework, adhering to Ghanaian healthcare regulations and data protection laws. The joint venture incorporates robust cybersecurity and business continuity protocols to safeguard patient data and system integrity.

The agreement recognizes regulatory alignment and data security as critical to the venture's credibility and sustainability, facilitating expansion within Ghana and potentially other Sub-Saharan African countries. Jospong's leadership in regulatory engagement, combined with MNDR's technical support, ensures the platform meets Ghana's evolving healthcare and data protection standards while maintaining operational resilience for diverse stakeholders.

Strategic Importance and MNDR's Africa Expansion Timeline

MNDR Co-CEO Dr. Siaw Tung Yeng described the agreement as transitioning the company's Africa strategy "from vision to execution." Ghana is positioned as MNDR's inaugural African market, serving as an entry point rather than the final destination. MNDR aims to develop a scalable, repeatable platform serving patients, healthcare providers, employers, and systems across Sub-Saharan Africa.

The partnership with Jospong aligns with MNDR's asset-light, technology-led growth model, leveraging proprietary technology and expertise while delegating local execution, regulatory navigation, and market development to a well-established Ghanaian conglomerate with extensive operations across Africa and Asia.

Jospong Group's Market Presence and Operational Strengths

Based in Accra, Ghana, Jospong Group of Companies is a diversified holding company with a significant footprint in West Africa, other African nations, and Asia. Founded in 1995, it comprises over 70 subsidiaries across more than 14 sectors, including waste management, ICT, banking, healthcare, insurance, logistics, and real estate.

Jospong Executive Chairman Dr. Joseph Siaw Agyepong highlighted healthcare digitization as a key growth opportunity for Ghana and the region. The collaboration combines Jospong's extensive local reach and operational expertise with MNDR's proprietary digital healthcare technology to build a secure, compliant, and scalable healthcare ecosystem. The partnership aims to enhance healthcare access, improve health outcomes, and establish Ghana as a hub for digital health innovation in Africa.

Commercial Models and Market Potential

MHNS Ghana Limited plans multiple revenue streams, including teleconsultation services utilizing MNDR's telemedicine infrastructure, integration with diagnostic services, patient engagement tools, data analytics for healthcare providers, employer health benefits tailored to workforce needs, a curated healthcare marketplace, and communities of care fostering peer support and education.

This diversified commercial approach addresses Ghana's fragmented healthcare access challenges. The phased rollout enables testing market demand, refining services, and optimizing user experience before full ecosystem expansion or regional scaling.

Regulatory Approval Process and Operational Timeline

The joint venture's commencement depends on obtaining necessary regulatory and statutory approvals from Ghanaian authorities. The announcement does not specify timelines for approvals or the start of Phase 1 activities. Investors should be aware that regulatory timelines for healthcare and digital health initiatives in emerging markets can be unpredictable and subject to delays or additional requirements.

No specific milestones, target dates, or contingency plans for extended approval timelines were disclosed. The forward-looking statements highlight regulatory approval completion as a material risk, alongside successful execution of the business plan, technology localization, user and partner acquisition, and compliance with healthcare and data protection laws.

Forward-Looking Statements and Associated Risks

The announcement includes detailed forward-looking statements outlining risks that could cause actual outcomes to differ materially. These risks encompass regulatory approval challenges, business plan execution, technology deployment, market adoption, legal compliance, cybersecurity, operational risks, and regional expansion timelines.

Additional risks are detailed in MNDR's filings with the U.S. Securities and Exchange Commission. Readers are cautioned against undue reliance on forward-looking statements, which reflect information as of July 27, 2026. MNDR disclaims any obligation to update these statements except as required by law. The immediate impact on MNDR's share price was not evident from available public data at the time of the announcement.